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Acute Intervention During Myocardial Infarction in Patients with Prior 
Coronary Bypass Surgery - 
Kevin M. Kavanaugh, MD, and Eric J. Topol, MD 
T 
hrombolytic intervention with or without coronary 
angioplasty is becoming widely accepted as standard 
therapy for patients who present early with acute myo- 
cardial infarction, Thrombolytic therapy has been shown 
to improve left ventricular function* and reduce mortali- 
ty.2 Nearly all clinical trials of myocardial reperfusion 
have excluded patients with a history of coronary artery 
bypass grafting. Furthermore, the only available data for 
the use of thrombolytic agents in this patient group con- 
sist of case reports of intracoronary thrombolytic agents3 
and a small series of intravenous thrombolytic agents4 
There are no published data for the use of angioplasty or 
combined thrombolysis and angioplasty in patients with 
acute infarction after bypass surgery. Considering the 
increasing number of patients undergoing coronary ar- 
tery bypass grafting and their propensity for future cardi- 
ac events,5 important questions regarding the optimal 
treatment strategy for prior coronary artery bypass pa- 
tients come to bear. Accordingly, we reviewed our experi- 
ence in the treatment of patients after coronary artery 
bypass surgery in the setting of evolving myocardial in- 
farction. 
Records from the University of Michigan Cardiac 
Catheterization Laboratory were reviewedfrom January 
I, 1984, to December 30, 1987, and a database of pa- 
tients with a history of coronary artery bypass grafting 
and acute myocardial infarction was tabulated. Acute 
myocardial infarction was diagnosed when an episode of 
characteristic chest pain lasting 130 minutes was asso- 
ciated with a transient, temporally appropriate increase 
of the total serum creatine phosphokinase above the 
upper limit of normal with myocardial isoenzyme frac- 
tion greater than twice normal. Data were compiled re- 
garding the presence and type of standard electrocardio- 
gram tracings at the time of infarction. Details of acute 
interventions, when performed, were accumulated, in- 
cluding those concerning the infarct-related vessel and 
whether or not the patient was treated with thrombolytic 
agents, direct angioplasty or a combination of the 2. 
Status of the infarct-related vessel after intervention was 
also noted. Follow-up data regarding hospital dis- 
charge, repeat catheterization, exercise stress testing and 
the needforfurther intervention, including repeat bypass 
surgery, were also obtained. 
Data are expressed as mean f 1 standard deviation. 
A comparison of the efficacy of acute intervention as 
defined by infarct-related vessel patency after interven- 
tion was estimated by examining a cohort of patients 
who presented with acute myocardial infarction and had 
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no previous history of bypass surgery treated with 
thrombolysis ana’/or angioplasty in the Thrombolysis 
and Angioplasty in Myocardial Infarction-l trial.6 Esti- 
mations of statistical significance were made using a chi- 
square test. 
As listed in Table I, 40 patients met the criteria 
delineated previously during the time frame stated. The 
time since coronary artery bypass was 6 f 3.5 years 
(range 2 months to 16 years). Age of the patients was 57 
f 10 years (range 33 to 77); 31 of 40 were male (72%). 
Although all patients presented with symptoms consis- 
tent with acute myocardial infarction and subsequently 
ruled in by enzymatic criteria, only 21 of 40 (53%) had 
typical ST-segment elevation or new Q waves. The re- 
mainder presented with ST depression or nonspecific 
electrocardiogram changes, thus not allowing localiza- 
tion of the site of myocardial infarction by these means. 
Thirty-five of the patients (88%) underwent diagnostic 
cardiac catheterization within close temporal relation to 
the onset of their symptoms. Of these patients, the in- 
farct-related vessel could be reliably identified in 26 
(74%); 12 were native vessel occlusions (46%) and 14 
were saphenous vein grafts (54%). Left internal thoracic 
artery grafts were not present in any of our patients. 
Acute intervention was attempted in 20 of these patients 
in whom the infarct-related vessel could be ascertained. 
The time from onset of symptoms to intervention was 4 
f 1 hours (range 2 to 6). 
Intravenous thrombolysis was only used in 4 (10%) of 
the patients (100 mg of recombinant tissue plasminogen 
activator in 2 cases, 1.5 million U of intravenous strepto- 
kinase in 1 case and 500,000 U of urokinase in 1 case) 
and was successful in establishing vessel patency in 3 
(75%). The infarct-related artery of the patient with 
unsuccessful reperfusion was a native right coronary ar- 
tery. Direct coronary angioplasty of the infarct-related 
vessel was performed in 9 patients (23%) and vessel 
patency was achieved in 7 (78%). The 2 unsuccessful 
coronary angioplasties were in saphenous vein grafts, 1 
to the left anterior descending artery and 1 to an obtuse 
marginal branch. Combined angioplasty and thrombo- 
lytic therapy (intracoronary urokinase or streptokinase) 
was performed in 7 patients and resulted in reperfusion 
in 6 (86%). The unsuccessful combined therapy was in a 
patient with a native right coronary as the infarct-related 
vessel. Angiographically demonstrable embolic compli- 
cations were not noted. The total success rate of all acute 
interventions in establishing infarct-related vessel paten- 
cy was 16 of 20 (80%). A similarly treated cohort of 
patients obtained from the Thrombolysis and Angio- 
plasty in Myocardial Infarction trials revealed a reper- 
fusion rate of 92% in 855 patients with native coronary 
artery thrombosis receiving thrombolysis and/or coro- 
nary angioplasty (p = 0.06). Of the patients not undergo- 
ing acute percutaneous intervention in this study, 2 had 












57, M 6 NQMI Medical Undetermined Undetermined - Negative ETT 
51, M 5 Anterior PTCA Anterior SVG-LAD + Died 
46 F 0.5 Inferior Medical Inferior Right - Patent artery at 1 yr 
55. F 1 NQMI CABG Undetermined Undetermined - Negative ETT 
70. M 16 NQMI Medical Inferior Undetermined - Unknown 
56, M 7 Inferior Medical Inferior OM Negative ETT 
43, F 2 Inferior Combined Inferior Right 0 PTCA of nonlRV 
57, M 5 NQMI Medical Undetermined Undetermined - Died 
43, M 2 Inferior Combined Inferior Right + Patent artery at 6 months 
51, M 5 Inferior Combined Inferior SIG-RCA + Restenosed IRV, unsuccessful PTCA 
47, F 5 Inferior Combined Inferior Right + Restenosed IRV. successful PTCA 
58, M 9 NQMI Medical Undetermined Undetermined - Died 
5%. M 3 Inferior Medical Inferior SVG Right - Negative ETT 
45. F 11 Inferior Thrombolysis inferior SVG Right + PTCA of Residual Stenosis 
76, M 3 NQMI Medical Undetermined Undetermined - Negative ETT 
61, M 6 NQMI Medical Undetermined LAD - Delayed PTCA of IRV 
56, M 6 Inferior Combined Inferior SVG-OM + Repeat CABG 
55, F a NQMI PTCA Undetermined SVG-OM 0 Died 3 months later 
56, M a NQMI PTCA Undetermined SVG-LC + Repeat CABG 
58, F 5 NQMI CABG Undetermined Undetermined - Died 
67, M 13 Inferior Medical Inferior SVG-Right Unsuccessful PTCA of IRV 
56, M 11 Inferior Thrombolysis Inferior SVG-OM + Delayed PTCA of IRV 
65. F 6 Anterior Thrombolysis Anterior SVG-LAD + IRV patent, negative ETT 
56, M 4 NQMI Medical Undetermined LC - Repeat CABG 
60. M 6 Inferior Combined Inferior Rrght + Patent IRV at repeat angiography 
49, M 3 NQMI PTCA Undetermined SVG-LAD 0 Repeat CABG 
57, M 6 NQMI PTCA Undetermined SVG-OM -I- Negative ETT 
60. M 6 NQMI PTCA Undetermined SVG-OM + Negative ETT 
57, M 10 NQMI Medrcal Undetermined Undetermined - Repeat CABG 
77, M 10 NQMI Medical Undetermined Undetermined - Died 2 months later 
62, M 0.25 Inferior PTCA Inferior SVG-OM + Positive ETT. medical therapy 
33, M 0.1 Inferior PTCA Inferior Right + Patent IRV at repeat angiography 
75, F 6 NQMI Medical Undetermined Undetermined - Died 3 months later 
64, M 11 NQMI Medical Undetermined Undetermined - Unknown 
72, M 5 NQMI Medical Undetermined Undetermined - Negative ETT 
44, M 4 Inferior PTCA Inferior Right + Patent IRV at repeat angiography 
62, M 5 Inferior Combined Inferior Right + Negative ETT 
61, M 7 NQMI Medical Undetermined Undetermined - Died 4 months later 
51. M 6 Inferior Thrombolysis Inferior Right 0 Delayed PTCA of IRV 
63, M 10 Inferior Medical Inferior Undetermined - Died 3 months later 
CABG = coronary artery bypass graft; Combined = treatment with thrombolysis and angloplasty: ECG = electrocardiogram; ‘i3T = exercise tolerance test; IRV = infarct-related 
vessel; LAD = left anterior descending artery; LC = left circumflex artery; MI = myocardial infarction; NQMI = non-Q-wave myocardlal InfarctIon; OM = obtuse marginal; PTCA = per- 
cutaneous transluminal coronary angioplasty; SVG = saphenousvein graft; + = yes; 0 = no. 
emergency repeat coronary artery bypass grafting and 
the remaining 18 were treated medically. 
Four patients died in the hospital (10%). Two of 
these patients had been treated medically; 1 died during 
emergency repeat coronary artery bypass surgery and 
the other died during acute coronary angioplasty (with- 
out combined thrombolysis). The intermediate-term 
postdischarge outcome was available in 38 of 40 pa- 
tients. There were 4 deaths within thefirst 3 months, 3 in 
patients who had been treated medically and I by acute 
intervention with angioplasty only. Five patients had re- 
peat coronary artery bypass grafting, 2 of whom had 
been treated medically, 2 by angioplasty only and 1 by 
combined thrombolysis and angioplasty. Eight patients 
had further revascularization by coronary angioplasty. 
Three of the 4 patients treated by thrombolysis alone 
had angioplasty of a residual stenosis of the infarct- 
related vessel. Two patients from the group initially 
treated with combined angioplasty and thrombolysis 
had restenosis of the infarct-related artery of which one 
was successfully dilated. One other patient from the 
combined treatment group had a delayed angioplasty of 
a noninfarct-related artery. Two patients in the medical- 
ly treated group had delayed angioplasties; 1 was suc- 
cessful. Thus, 8 of 20 patients (40%) initially treated 
with acute intervention went on to have successful revas- 
cularization procedures after their acute infarct; I was 
lost to follow-up and 1 died. The remainder had patent 
infarct-related arteries at recatheterization or were 
asymptomatic clinically. 
The number of patients undergoing coronary artery 
bypass grafting with saphenous vein grafts has been 
steadily increasing.’ Considering that the rate of late 
graft occlusion is approximately 4%/year8 and the yearly 
rate of myocardial infarction after coronary artery by- 
pass surgery is approximately ~‘SJ,~ the number of pa- 
tients at risk for these events continues to increase. Thus, 
this group of patients represents an increasing proportion 
of cases of acute myocardial infarction that may benefit 
from acute intervention. However, the experience on the 
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use of thrombolytic agents or angioplasty in these pa- 
tients remains very limited. 
This study reports our experience in patients after 
coronary artery bypass grafting in the setting of acute 
myocardial infarction. Although the number of patients 
available for review is small when compared to large scale 
clinical trials, it represents a large series of such patients 
reported to date. Furthermore, we report all such patients 
presenting to our institution regardless of whether or not 
an intervention was performed. 
We noted a limited ability of the standard electrocar- 
diogram to corroborate acute myocardial infarction and 
aid in ability to determine the infarct area. The prepon- 
derance of non-Q-wave myocardial infarcts in our study 
probably relates to either the finding that the infarct- 
related vessel is less likely to be a main epicardial arterylo 
or to the presence of collaterals. Thus, such infarcts are 
usually smaller in postcoronary artery bypass surgery 
patients.” This observation may impede the ability to 
promptly intervene in these patients when they present 
with acute myocardial infarction. 
Furthermore, even with angiography the infarct- 
related vessel could not be reliably identified in a fairly 
large proportion of our patients. This phenomenon was 
due to the presence of >l vessel occlusion or multiple 
discordant wall motion abnormalities. With our concern 
over patient safety intervention with direct angioplasty or 
intracoronary thrombolysis was not possible in this group. 
However, in our patients in whom the infarct-related 
vessel could be ascertained and acute intervention was 
performed, the results as assessed by vessel patency com- 
pared less favorably with a cohort of patients who never 
had bypass surgery. Although the lesions encountered in 
these patients may have been somewhat more “resistant” 
to thrombolytic therapy or angioplasty, there was yet a 
high degree of success. We did not encounter overt angio- 
graphic evidence of embolic complications as reported by 
others.12 Furthermore, more definitive revascularization 
with redo surgery was then possible in many of these 
patients at a later date. The limited number of patients in 
our study preclude recommendations as to the general 
treatment of such patients. However, based on this expe- 
rience acute intervention in this setting is a viable option, 
albeit with a decreased reperfusion success rate, but with 
a potentially positive impact on the prognosis of these 
patients. There appears to be no legitimate reason to 
exclude this important group of patients from prospective 
reperfusion trials. 
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Effects of Verapamil on the Anaerobic Threshold and Peak Oxygen 
Consumption in Effort Angina Pectoris 
Andrew Thomson, MB, PhD, FRACP, and David T. Kelly, MB, FRACP 
T he anaerobic threshold is the submaximal level of exertion above which lactic acid progressively accu- 
mulates in the blood and fatigue progressively increases 
during incremental exercise. lv2 The anaerobic threshold is 
a useful clinical measurement of submaximal exercise 
performance in normal subjects1-3 and in patients with 
congestive heart failure,4 angina pect0ri.G and valvular 
regurgitation,6 and has been used to assess drug interven- 
tions.’ In patients with effort angina, ST-segment depres- 
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sion is reduced and exercise time increased after calcium 
antagonists.8y9 If relief of myocardial ischemia by verapa- 
mil allows an improvement in peak oxygen consumption 
(VO@&), there may also be an improvement in oxygen 
metabolism by exercising muscle and the anaerobic 
threshold may increase, delaying the onset of fatigue. 
This study determines whether verapamil alters the oxy- 
gen consumption (VO2) at the anaerobic threshold, or the 
perception of leg fatigue in patients with effort angina 
pectoris. 
Sixteen patients with stable exertional angina pecto- 
ris and positive exercise tests (Bruce protocol with at 
least 1 -mm horizontal ST-segment depression) entered 
the stu@. No patient had chronic lung disease, valvular 
regurgitation, clinical heart failure or peripheral vascu- 
lar disease. All patients gave written informed consent 
